Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review of gene therapies for age-related macular degeneration.
Khanani AM, Thomas MJ, Aziz AA, Weng CY, Danzig CJ, Yiu G, Kiss S, Waheed NK, Kaiser PK. Khanani AM, et al. Among authors: weng cy. Eye (Lond). 2022 Feb;36(2):303-311. doi: 10.1038/s41433-021-01842-1. Epub 2022 Jan 11. Eye (Lond). 2022. PMID: 35017696 Free PMC article. Review.
Abicipar pegol for neovascular age-related macular degeneration.
Hussain RM, Weng CY, Wykoff CC, Gandhi RA, Hariprasad SM. Hussain RM, et al. Among authors: weng cy. Expert Opin Biol Ther. 2020 Sep;20(9):999-1008. doi: 10.1080/14712598.2020.1782379. Epub 2020 Jul 3. Expert Opin Biol Ther. 2020. PMID: 32552072
Port delivery system: a novel drug delivery platform to treat retinal diseases.
Khanani AM, Aziz AA, Weng CY, Lin WV, Vannavong J, Chhablani J, Danzig CJ, Kaiser PK. Khanani AM, et al. Among authors: weng cy. Expert Opin Drug Deliv. 2021 Nov;18(11):1571-1576. doi: 10.1080/17425247.2021.1968826. Epub 2021 Aug 24. Expert Opin Drug Deliv. 2021. PMID: 34388956 Review.
Angiopoietins as Potential Targets in Management of Retinal Disease.
Khanani AM, Russell MW, Aziz AA, Danzig CJ, Weng CY, Eichenbaum DA, Singh RP. Khanani AM, et al. Among authors: weng cy. Clin Ophthalmol. 2021 Sep 4;15:3747-3755. doi: 10.2147/OPTH.S231801. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34511878 Free PMC article. Review.
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.
Rodrigues IA, Sprinkhuizen SM, Barthelmes D, Blumenkranz M, Cheung G, Haller J, Johnston R, Kim R, Klaver C, McKibbin M, Ngah NF, Pershing S, Shankar D, Tamura H, Tufail A, Weng CY, Westborg I, Yelf C, Yoshimura N, Gillies MC. Rodrigues IA, et al. Among authors: weng cy. Am J Ophthalmol. 2016 Aug;168:1-12. doi: 10.1016/j.ajo.2016.04.012. Epub 2016 Apr 27. Am J Ophthalmol. 2016. PMID: 27131774 Free article.
Treatment of Diabetic Macular Edema.
Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Kim EJ, et al. Among authors: weng cy. Curr Diab Rep. 2019 Jul 29;19(9):68. doi: 10.1007/s11892-019-1188-4. Curr Diab Rep. 2019. PMID: 31359157 Review.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
264 results